Company / Operating Income per Share
Vir Biotechnology, Inc. Operating Income per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.50
FY2025
5-year range
-$5.14 / -$1.40
FY2021-FY2025
Trend
+19.7%
vs FY2024
Sector context
#151 of 201
Health Care
What the data says
Vir Biotechnology, Inc.'s operating income per share of $-3.50 is lower than 75% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 9 years, ranging from $-37.87 in FY2017 to $-1.40 in FY2021.
Based on SEC 10-K filings.
-3.50 in FY2025.
Improved from $-5.14 to $-3.50 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 201This company -$3.50 Sector average -$28.56
▼
+87.7% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 19.7% year-over-year.
- Ranks #151 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.50 | +19.7% |
| FY2024 | -$4.36 | +15.2% |
| FY2023 | -$5.14 | -126.8% |
| FY2022 | -$2.26 | -62.1% |
| FY2021 | -$1.40 | +49.4% |
| FY2020 | -$2.76 | +86.3% |
| FY2019 | -$20.09 | -29.8% |
| FY2018 | -$15.48 | +59.1% |
| FY2017 | -$37.87 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026